The Polycomb Protein Bmi1 Plays a Crucial Role in the Prevention of 1,25(OH)2D Deficiency-Induced Bone Loss

We analyzed the skeletal phenotypes of heterozygous null Cyp27b1 (Cyp27b1(+/-)) mice and their wild-type (WT) littermates to determine whether haploinsufficiency of Cyp27b1 accelerated bone loss, and to examine potential mechanisms of such loss. We found that serum 1,25-dihydroxyvitamin D [1,25(OH)(2)D] levels were significantly decreased in aging Cyp27b1(+/-) mice, which displayed an osteoporotic phenotype. This was accompanied by a reduction of expression of the B lymphoma Moloney murine leukemia virus (Mo-MLV) insertion region 1 (Bmi1) at both gene and protein levels. Using chromatin immunoprecipitation (ChIP)-PCR, electrophoretic mobility shift assay (EMSA) and a luciferase reporter assay, we then showed that 1,25(OH)(2)D-3 upregulated Bmi1 expression at a transcriptional level via the vitamin D receptor (VDR). To determine whether Bmi1 overexpression in mesenchymal stem cells (MSCs) could correct bone loss induced by 1,25(OH)(2)D deficiency, we overexpressed Bmi1 in MSCs using Prx1-driven Bmi1 transgenic mice (Bmi1(Tg)) mice. We then compared the bone phenotypes of Bmi1(Tg) mice on a Cyp27b1(+/-) background, with those of Cyp27b1(+/-) mice and with those of WT mice, all at 8 months of age. We found that overexpression of Bmi1 in MSCs corrected the bone phenotype of Cyp27b1(+/-) mice by increasing osteoblastic bone formation, reducing osteoclastic bone resorption, increasing bone volume, and increasing bone mineral density. Bmi1 overexpression in MSCs also corrected 1,25(OH)(2)D deficiency-induced oxidative stress and DNA damage, and cellular senescence of Cyp27b1(+/-) mice by reducing levels of reactive oxygen species (ROS), elevating serum total superoxide dismutase levels, reducing the percentage of gamma H(2)A.X, p16, IL-1 beta, and TNF-alpha-positive cells and decreasing gamma H2A.X, p16, p19, p53, p21, IL-1 beta, and IL-6 expression levels. Furthermore, 1,25(OH)(2)D stimulated the osteogenic differentiation of MSCs, both ex vivo and in vitro, from WT mice but not from Bmi1(-/-) mice and 1,25(OH)(2)D administration in vivo increased osteoblastic bone formation in WT, but not in Bmi1(-/-) mice. Our results indicate that Bmi1, a key downstream target of 1,25(OH)(2)D, plays a crucial role in preventing bone loss induced by 1,25(OH)(2)D deficiency. (c) 2019 American Society for Bone and Mineral Research.